Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Original Article

Hepatitis B screening rates and reactivation in solid organ malignancy patients undergoing chemotherapy in Southern Thailand

Ratchapong Laiwatthanapaisan, Pimsiri Sripongpun, Naichaya Chamroonkul, Arunee Dechaphunkul, Chirawadee Sathitruangsak, Siwat Sakdejayont, Chanon Kongkamol, Teerha Piratvisuth

Clin Mol Hepatol. 2019;25(4):366-373. Published online July 17, 2019

DOI: https://doi.org/10.3350/cmh.2018.0111

View: 5288 Download: 111 Web of Science: 3 Crossref: 5

Review

Upcoming direct acting antivirals for hepatitis C patients with a prior treatment failure

Tommaso Lorenzo Parigi, Maria Corina Plaz Torres, Alessio Aghemo

Clin Mol Hepatol. 2019;25(4):360-365. Published online May 2, 2019

DOI: https://doi.org/10.3350/cmh.2019.0022

View: 5679 Download: 243 Web of Science: 9 Crossref: 10

Appropriate treatment modality for solitary small hepatocellular carcinoma: Radiofrequency ablation vs. resection vs. transplantation?

Keun Soo Ahn, Koo Jeong Kang

Clin Mol Hepatol. 2019;25(4):354-359. Published online April 22, 2019

DOI: https://doi.org/10.3350/cmh.2018.0096

View: 7855 Download: 361 Web of Science: 42 Crossref: 41

Ultraselective conventional transarterial chemoembolization: When and how?

Shiro Miyayama

Clin Mol Hepatol. 2019;25(4):344-353. Published online April 26, 2019

DOI: https://doi.org/10.3350/cmh.2019.0016

View: 11392 Download: 561 Web of Science: 29 Crossref: 32

Detect or not to detect very early stage hepatocellular carcinoma? The western perspective

Ju Dong Yang

Clin Mol Hepatol. 2019;25(4):335-343. Published online March 29, 2019

DOI: https://doi.org/10.3350/cmh.2019.0010

View: 11074 Download: 246 Web of Science: 41 Crossref: 41

Editorial

A leap for the journal: Clinical and Molecular Hepatology enters a new era

Yoon Jun Kim

Clin Mol Hepatol. 2019;25(4):333-334. Published online December 17, 2019

DOI: https://doi.org/10.3350/cmh.2019.1004

View: 4244 Download: 57

Letter to the Editor

Serum leptin in non-alcoholic fatty liver disease: Ambiguous clinical implications concerning cardiovascular disease

Dimitrios Patoulias, Konstantinos Imprialos, Konstantinos Stavropoulos, Michael Doumas

Clin Mol Hepatol. 2019;25(3):331-332. Published online May 30, 2019

DOI: https://doi.org/10.3350/cmh.2019.0034

View: 4449 Download: 56 Crossref: 1

Letter to the editor

Ombitasvir/paritaprevir/ritonavir+dasabuvir and ribavirin associated drug-induced liver injury and syndrome of inappropriate secretion of anti-diuretic hormone: A case report

Rahul Kumar, John Chen Hsiang, Jessica Tan, Prem Harichander Thurairajah

Clin Mol Hepatol. 2019;25(3):326-330. Published online December 4, 2018

DOI: https://doi.org/10.3350/cmh.2018.0063

View: 11409 Download: 104 Web of Science: 3 Crossref: 4

Original Article

Underlying liver disease and advanced stage liver cancer are associated with elevated neutrophil-lymphocyte ratio

Linda Wong, Kliment Bozhilov, Brenda Hernandez, Sandi Kwee, Owen Chan, Luke Ellis, Loic LeMarchand

Clin Mol Hepatol. 2019;25(3):305-316. Published online April 19, 2019

DOI: https://doi.org/10.3350/cmh.2019.0004

View: 6540 Download: 169 Web of Science: 25 Crossref: 24

Effects of different exercise modalities on novel hepatic steatosis indices in overweight women with type 2 diabetes

Ebrahim Banitalebi, Mohammad Faramarzi, Samira Nasiri, Majid Mardaniyan, Vahid Rabiee

Clin Mol Hepatol. 2019;25(3):294-304. Published online May 30, 2019

DOI: https://doi.org/10.3350/cmh.2018.0086

View: 7281 Download: 258 Web of Science: 13 Crossref: 17

Influence of hepatic steatosis on the outcomes of patients with chronic hepatitis B treated with entecavir and tenofovir

David Sooik Kim, Mi Young Jeon, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Seung Up Kim

Clin Mol Hepatol. 2019;25(3):283-293. Published online November 13, 2018

DOI: https://doi.org/10.3350/cmh.2018.0054

View: 10377 Download: 245 Web of Science: 30 Crossref: 33

Editorial

How does hepatic steatosis affect the outcome of patients with chronic hepatitis B?

Jung Hwan Yu, Jin-Woo Lee

Clin Mol Hepatol. 2019;25(3):280-282. Published online January 21, 2019

DOI: https://doi.org/10.3350/cmh.2018.0104

View: 5636 Download: 125 Web of Science: 1 Crossref: 1

Review

Sarcopenia: Ammonia metabolism and hepatic encephalopathy

Ankur Jindal, Rakesh Kumar Jagdish

Clin Mol Hepatol. 2019;25(3):270-279. Published online April 22, 2019

DOI: https://doi.org/10.3350/cmh.2019.0015

View: 16738 Download: 927 Web of Science: 63 Crossref: 69

Hepatocellular carcinoma surveillance in the 21st century: Saving lives or causing harm?

Ibrahim A. Hanouneh, Naim Alkhouri, Amit G. Singal

Clin Mol Hepatol. 2019;25(3):264-269. Published online March 4, 2019

DOI: https://doi.org/10.3350/cmh.2019.1001

View: 9980 Download: 328 Web of Science: 47 Crossref: 47

Comparison of international guidelines for noninvasive diagnosis of hepatocellular carcinoma: 2018 update

Tae-Hyung Kim, So Yeon Kim, An Tang, Jeong Min Lee

Clin Mol Hepatol. 2019;25(3):245-263. Published online February 14, 2019

DOI: https://doi.org/10.3350/cmh.2018.0090

View: 19020 Download: 1,043 Web of Science: 144 Crossref: 151

Development and surveillance of hepatocellular carcinoma in patients with sustained virologic response after antiviral therapy for chronic hepatitis C

Seong Kyun Na, Byung-Cheol Song

Clin Mol Hepatol. 2019;25(3):234-244. Published online January 21, 2019

DOI: https://doi.org/10.3350/cmh.2018.0108

View: 8353 Download: 248 Web of Science: 21 Crossref: 23

Gadoxetic acid-enhanced magnetic resonance imaging: Hepatocellular carcinoma and mimickers

Yeun-Yoon Kim, Mi-Suk Park, Khalid Suliman Aljoqiman, Jin-Young Choi, Myeong-Jin Kim

Clin Mol Hepatol. 2019;25(3):223-233. Published online January 21, 2019

DOI: https://doi.org/10.3350/cmh.2018.0107

View: 10769 Download: 412 Web of Science: 29 Crossref: 32

Original Article

Are there differences in risk factors, microbial aspects, and prognosis of cellulitis between compensated and decompensated hepatitis C virus-related cirrhosis?

Elham Ahmed Hassan, Abeer Sharaf El-Din Abdel Rehim, Mohamed Omar Abdel-Malek, Asmaa Omar Ahmed, Nourhan Mahmoud Abbas

Clin Mol Hepatol. 2019;25(3):317-325. Published online June 10, 2019

DOI: https://doi.org/10.3350/cmh.2018.0097

View: 9989 Download: 123 Web of Science: 2 Crossref: 1

Letter to the editor

VIEKIRA PAK associated drug-induced interstitial lung disease: Case series with systematic review of literature

Yu Jun Wong, Si Yuan Chew, John Chen Hsiang, Prem Harichander Thurairajah, Rahul Kumar, Eng Kiong Teo, Roshni Sadashiv Gokhale, Imran Bin Mohamed Noor, Jessica Tan

Clin Mol Hepatol. 2019;25(2):218-222. Published online September 6, 2018

DOI: https://doi.org/10.3350/cmh.2018.0017

View: 11027 Download: 121 Web of Science: 1 Crossref: 2

Original Article

Portal pressure gradient and serum albumin: A simple combined parameter associated with the appearance of ascites in decompensated cirrhosis treated with transjugular intrahepatic portosystemic shunt

Dongmei Zhao, Guobing Zhang, Mingquan Wang, Chaoxue Zhang, Jiabin Li

Clin Mol Hepatol. 2019;25(2):210-217. Published online March 22, 2019

DOI: https://doi.org/10.3350/cmh.2018.0083

View: 6048 Download: 122 Web of Science: 5 Crossref: 5

Effects of zolpidem on sleep parameters in patients with cirrhosis and sleep disturbances: A randomized, placebo-controlled trial

Manoj Kumar Sharma, Sumeet Kainth, Sachin Kumar, Ankit Bhardwaj, Hemant Kumar Agarwal, Rakhi Maiwall, Kapil Dev Jamwal, Saggere Muralikrishna Shasthry, Ankur Jindal, Ashok Choudhary, Lovkesh Anand, Rajender Mal Dhamija, Guresh Kumar, Barjesh Chander Sharma, Shiv Kumar Sarin

Clin Mol Hepatol. 2019;25(2):199-209. Published online March 11, 2019

DOI: https://doi.org/10.3350/cmh.2018.0084

View: 14074 Download: 273 Web of Science: 20 Crossref: 21

Evaluation of bioenergetic and mitochondrial function in liver transplantation

Rui Miguel Martins, João Soeiro Teodoro, Emanuel Furtado, Anabela Pinto Rolo, Carlos Marques Palmeira, José Guilherme Tralhão

Clin Mol Hepatol. 2019;25(2):190-198. Published online March 22, 2019

DOI: https://doi.org/10.3350/cmh.2018.0087

View: 7113 Download: 166 Web of Science: 7 Crossref: 6

Endoscopic treatment or balloon-occluded retrograde transvenous obliteration is safe for patients with esophageal/gastric varices in Child-Pugh class C end-stage liver cirrhosis

Keiji Yokoyama, Ryo Yamauchi, Kumiko Shibata, Hiromi Fukuda, Hideo Kunimoto, Kazuhide Takata, Takashi Tanaka, Shinjiro Inomata, Daisuke Morihara, Yasuaki Takeyama, Satoshi Shakado, Shotaro Sakisaka

Clin Mol Hepatol. 2019;25(2):183-189. Published online November 9, 2018

DOI: https://doi.org/10.3350/cmh.2018.0039

View: 6514 Download: 139 Web of Science: 10 Crossref: 12

Editorial

Role of endoscopic treatment or balloon-occluded retrograde transvenous obliteration in patients with Child-Pugh class C end-stage liver cirrhosis and esophageal/gastric varices

Jin Wook Chung

Clin Mol Hepatol. 2019;25(2):181-182. Published online December 21, 2018

DOI: https://doi.org/10.3350/cmh.2018.1010

View: 5582 Download: 127 Web of Science: 2 Crossref: 2

Review

Unmet need in chronic hepatitis B management

Lilian Yan Liang, Grace Lai-Hung Wong

Clin Mol Hepatol. 2019;25(2):172-180. Published online February 12, 2019

DOI: https://doi.org/10.3350/cmh.2018.0106

View: 9593 Download: 399 Web of Science: 43 Crossref: 45

Direct-acting antivirals response in hepatocellular carcinoma: Does the presence of hepatocellular carcinoma matter?

Chung-Feng Huang, Ming-Lung Yu

Clin Mol Hepatol. 2019;25(2):168-171. Published online February 11, 2019

DOI: https://doi.org/10.3350/cmh.2018.1014

View: 6002 Download: 180 Web of Science: 4 Crossref: 5

Advances in ultrasound diagnosis in chronic liver diseases

Hitoshi Maruyama, Naoya Kato

Clin Mol Hepatol. 2019;25(2):160-167. Published online February 18, 2019

DOI: https://doi.org/10.3350/cmh.2018.1013

View: 11367 Download: 475 Web of Science: 22 Crossref: 22

KASL clinical practice guidelines for management of chronic hepatitis B

Clin Mol Hepatol. 2019;25(2):93-159. Published online June 12, 2019

DOI: https://doi.org/10.3350/cmh.2019.1002

View: 24954 Download: 649 Web of Science: 166 Crossref: 149

Letter to the Editor

Biochemical profile in an infant with neonatal hemochromatosis shows evidence of impairment of mitochondrial long-chain fatty acid oxidation

Karina Lucio de Medeiros Bastos, Caio Robledo Quaio, Fabiana Roberto Lima, Iana Manuelle Araújo, Candice Alves Tavares Araújo, Flávia Balbo Piazzon, Ismael Dale Cotrim Guerreiro da Silva, Gabriel Nuncio Benevides, Ana Cristina Tannuri, Uenis Tannuri, Ramiro Anthero Azevedo, Chong Ae Kim

Clin Mol Hepatol. 2019;25(1):86-91. Published online August 28, 2018

DOI: https://doi.org/10.3350/cmh.2018.0005

View: 8322 Download: 147 Web of Science: 2 Crossref: 1

Original Article

Safety margin of embolized area can reduce local recurrence of hepatocellular carcinoma after superselective transarterial chemoembolization

Kittipitch Bannangkoon, Keerati Hongsakul, Teeravut Tubtawee, Teerha Piratvisuth

Clin Mol Hepatol. 2019;25(1):74-85. Published online February 28, 2019

DOI: https://doi.org/10.3350/cmh.2018.0072

View: 7471 Download: 205 Web of Science: 21 Crossref: 23

Viewed By 5505	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5409	MAFLD: How is it different from NAFLD?
Viewed By 5220	Evaluating the therapeutic efficacy of NAD supplementation in management of metabolic dysfunction-associated steatotic liver disease: Key considerations
Viewed By 5098	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4732	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 176	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 113	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 108	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 90	MAFLD: How is it different from NAFLD?
Cited By 80	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach

Article category